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SUMMARY
Angio-oedema may be hereditary or acquired and is characterised by episodes of
potentially life threatening localised tissue oedema and swelling resulting from deficiency
of compliment pathway C1 esterase inhibitor. Acquired angio-oedema is about ten times
less frequent than the hereditary type and has been associated with immune-deficiency
disorders, malignancies and exposure to specific medications and food substances. We
present a case of seven year old, human immune-deficiency virus positive girl, who
developed gross swelling of the tongue and neck while on treatment for pneumococcal
meningitis with ceftriaxone. Difficulties in arriving at a definitive diagnosis of angio-
oedema in a resource poor country are discussed and alternative diagnostic options
proposed.
INTRODUCTION
Angio-oedema is a fairly uncommon clinical
syndrome characterised by episodes of potentially life
threatening localised tissue oedema and swelling resulting
from either hereditary or acquired deficiency of
compliment pathway C1 esterase inhibitor. Classically,
the swelling develops gradually over several hours,
increasing slowly over 12-36 hours and then subsides
over two to five days. Episodes resulting in upper
respiratory tract, including tongue, pharynx and larynx,
carry an estimated mortality rate of about 15-33% (1).
Most of the literature on this condition is based on small
case series and case reports. More than 100 different C1
inhibitor gene mutations have been described in the
hereditary type which is transmitted in an autosomal
dominant manner with a mutation rate of about 25% (2).
Acquired angio-oedema (AAE) is about ten times
less frequent than the hereditary type and more often
presents in older patients in association with
lymphoproliferative diseases, infections or autoimmune
disorders (3,4). Beta-lactam antibiotics like penicillins,
cephalosporins and monobactams, have also been
associated with immediate hypersensitivity reactions
characterised by urticaria, angio-oedema, rhinitis,
bronchospasm and anaphylactic shock within first hour
of administration (5). A few reports of AAE have been
reported in association with administration of food
substances and medications in human immuno-deficiency
virus (HIV) positive patients (6,7).
We report a case of a seven year old, HIV elisa-
test positive girl admitted in a children's hospital in
Nairobi, with the diagnosis of pneumococcal meningitis
who developed severe non-tender oedema of the tongue
and neck within six days of commencement of intra-
venous ceftriaxone treatment.
CASE REPORT
SWM was a seven-year old girl who presented at
Gertrude’s Garden Children’s Hospital with a two-day
history of severe headaches, neck pain and stiffness,
vomiting and fever. Though she had not received any
treatment for the current illness, she had previously
been on various types of antibiotics for upper airway
infections without any adverse events. She had no
known previous allergy to foods or drugs. SWM was
also a known asthmatic previously managed on
interrupted courses of oral salbutamol as necessary.
There was no history of travel to malaria endemic areas.
Early development was normal and all childhood
immunizations had been administered as per the Kenya
expanded immunization program schedule, which
included BCG, Oral polio, DPT and measles vaccine.
She was the only child in the family and her father
was reported to have died sometime back from probable
leukemia, though acquired immune-deficiency disease
exposure was suspected.
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Figure 1
Lateral view of the face showing a markedly swolen neck and tongue of a seven-year old, HIV positive
girl during treatment for bacterial meningitis with ceftriaxone
At admission, SWM was found to be restless,
febrile with a temperature of 38°C and had reduced
level of consciousness. She had neck stiffness, hypertonic
lower limbs but Kernig's test was negative. The pulse
rate was 160 per minute, regular breathing, no subcostal
recession nor flaring of ala-nasi. She had no sub-
conjunctival pallour, oedema nor jaundice. The throat
was normal and there was no evidence of dental caries
or gingivitis. A diagnosis of meningitis was entertained
and subsequently confirmed with isolation of
streptococcus pneumonia, sensitive to ceftriaxone, in
both cerebral spinal fluid and blood. Total leukocyte
count was 17.8xl09L with an absolute neutrophil count
of 15.5x109/L. HIV 1 and 2 ELISA test was positive,
blood smear for malaria parasites was negative, chest
X-ray was normal and renal function tests and random
blood sugar were also normal. On admission to the
intensive care unit, SWM was immediately commenced
on antimeningitic dose of ceftriaxone, paracetamol and
intra-venous fluids due to poor oral intake. Deteriorating
level of consciousness on the day of admission led to
endotracheal intubation and commencement of intra-
venous dexamethasone for probable increased intra-cranial
pressure. Protrusion and gross swelling of the tongue was
noted on the 6th post admission day (Figure 1) when the
patient was still on respiratory support. There was no
evidence of oral trauma, bleeding or local focus of
infection in the mouth or neck. No swellings or oedema
were identifiable in any other part of the body. Serum
proteins, repeat urea, creatinine and electrolytes were
normal. A clinical diagnosis of acquired angio-oedema
of the tongue was made and ceftriaxone replaced with
meropenem. Though the tongue swelling was regressing
two days later, the patient died on the ninth day of
admission. Laboratory facilities for determination of C1
esterase inhibitor, C4 or antibiotic antibodies were not
available. Parents declined to have post-mortem done.
DISCUSSION
A clinical diagnosis of meningitis in a HIV
positive patient was made in the index case right at
the time of admission and appropriate antibiotic treatment
commenced immediately. The causative agent was later
confirmed to be S. pneumoniae, which was sensitive
to ceftriaxone that the patient was already on. The
condition of the patient did not show any marked
improvement over several days. In Kenya  S. pneumoniae
has been shown to be responsible for 24% of meningitis
in children admitted to a District General Hospital (8),
but since the introduction of the Haemophilus influenza
type b conjugated vaccine the proportion has risen to
52%. Thirty six percent of children with pneumococcal
meningitis died during hospital admission while 32%
developed neurological deficits upon discharge.
Occurrence of marked oedema of the tongue on day
six of admission followed by neck swelling thereafter was
an intriguing new development. Possibilities of both
Ludwig's angina and angio-oedema were entertained.
Ludwig's angina usually presents with a rapidly increasing
cellulitis of the floor of the mouth characterised by a
brawny induration of the floor and suprahyoid region
bilaterally (9). As reported, there was no evidence of local
inflammation in this case and the mouth looked otherwise
normal, except for the oedema of the tongue. Though this
condition has become increasingly rare due to better
antibiotic access, de novo occurrence, without any
predisposing factors, has been reported in children(10,11).
Compromised immune system as in HIV/AIDS has been
cited among possible predisposing factors (12). In a series
of nine cases, Srirompotong found streptococcus species
to be the most common cause of the infection and was
successfully treated with high doses of intra-venous
antibiotics (9). Others have reported regression of cellulitis
and oedema following addition of high dose dexamethasone
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to the antibiotic treatment(13). It is noteworthy that our
patient was already on dexamethasone well before the
onset of the tongue and neck swelling thus indicating the
limitations of the steroid in prophylaxis in the presence
of an ongoing antigenic challenge.
AAE has been reported in association with
administration of certain food substances and medications
in human immune-deficiency virus positive patients (6,7).
SWM was not on any such food substances but was on
a third generation cephalosporin. Even in the absence of
immune-deficiency, beta-lactam antibiotics are reported to
be the most frequent causes of immediate immune allergic
reactions. Onset is usually within one hour of their
administration. Reactions are characterised by urticaria,
angio-oedema, rhinitis, bronchospasm and anaphylactic
shock (5). Mortality rate of angio-oedema has been
previously estimated to range between 15-33% (1). The
patient reported here developed the oedema and swelling
over several hours and a decrease was evident a few days
later following withdrawal of ceftriaxone, as would be
expected in angio-oedema(14). We were, unfortunately,
unable to confirm the diagnosis of angio-oedema.
Diagnosis of angio-oedema is based on demonstration
of a low or absent serum compliment C4 or/and reduced
C1 esterase inhibitor (14). Though overlooked in this case,
skin testing for cephalosporin hypersensitivity should have
been undertaken. Determination of specific IgE levels,
where available, would similarly constitute good evidence
for immediate allergic reaction in the absence of facilities
for serum complement level determinations(5). It was the
opinion of the authors that SWM experienced immediate
hypersensitivity reaction from ceftriaxone but died from
complications related to HIV and pneumococcal meningitis
rather than angio-oedema.
Cephalosporin hypersensitivity should be considered
in patients who develop angio-oedema on treatment.
Though its diagnostic utility may need local validation,
skin testing for patients with suspected antibiotic
hypersensitivity in resource poor environments should be
considered alongside determination of drug specific IgE
antibodies, compliment C4 and C1 esterase inhibitor.
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